Name: Recombinant Anti-FGFR1 x Anti-KLB Bispecific Antibody (scDiabody-CH3)
SKU: SCDBC-161
Rating: 5 (1 reviews)

Recombinant Anti-FGFR1 x Anti-KLB Bispecific Antibody (scDiabody-CH3) is a fusion protein of two scDiabodies connected together by a CH3 region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-FGFR1/anti-KLB diabody. The scDiabody with two specificities is fused to each of the CH3 chains to extend half-life. This BsAb can bind two factors simultaneously and act as mimetic hormone (FGF21) . It is designed for the research of Type 2 diabetes therapy.

Datasheet INQUIRY

Specifications

Targets

FGFR1 & KLB

Type

scDiabody-CH3

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Type 2 diabetes

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

FGFR1

Gene ID

2260

UniProt ID

P11362

Alternative Names

FGFR1; fibroblast growth factor receptor 1; CEK; FLG; HH2; OGD; ECCL; FLT2; KAL2; BFGFR; CD331; FGFBR; FLT-2; HBGFR; N-SAM; FGFR-1; HRTFDS; bFGF-R-1; basic fibroblast growth factor receptor 1; HBGFR; FMS-like tyrosine kinase 2

Target 2

KLB

Gene ID

152831

UniProt ID

Q86Z14

Alternative Names

klotho beta; BKL; KLB; Beta-klotho; B-klotho; BetaKlotho; klotho beta like 3

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-FGFR1 x Anti-KLB Bispecific Antibody (scDiabody-CH3) (SCDBC-161). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-FGFR1 x Anti-KLB Bispecific Antibody (scDiabody-CH3) (CAT#: SCDBC-161)

Specifications

Targets

Customer Reviews and Q&As